Avidity Reports Positive Phase 1/2 FSHD Data for Del-Brax
— Unprecedented data from FORTITUDE™ dose escalation cohorts for del-brax treated participants, compared to placebo, demonstrate improvement in function, strength and PROs as well as rapid...
Category : Public Health, Disease Prevention & Wellness
ERA Congress: Long-Term Data Show Zigakibart’s Efficacy in IgA Nephropathy
New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as a disease-modifying treatment for IgA nephropathy...
New Study Shows SyMRI’s Potential to Transform Neuroimaging Workflows
SyntheticMR AB (publ) is proud to share the results of a newly published multicenter clinical study in the American Journal of Neuroradiology (AJNR), demonstrating the...
ColoHealth Launches Direct-to-Consumer Colon Cancer Test
The lab-drawn screening test from New Day Diagnostics is available without a doctor’s order in most states and requires no special prep. New Day Diagnostics today...
Alcon Gets FDA OK for TRYPTYR to Treat Dry Eye Disease
Ad hoc announcement pursuant to Art. 53 LR Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S....
ISSA Launches GLP-1 Training for New Weight Loss Coaching Era
The International Sports Sciences Association (ISSA) has announced the launch of its comprehensive GLP-1 Weight Loss Support Training, designed to equip personal trainers, health coaches, and fitness...
Lars Rebien Sørensen to join the board of directors of Novo Nordisk A/S
Novo Nordisk A/S announced earlier today that Lars Rebien Sørensen, Chair of the Novo Nordisk Foundation, will join its board of directors, initially as an observer....
CE Health Interactive Launches Two CME Grant Programs
CE Health Interactive proudly announces the launch of two groundbreaking Continuing Medical Education (CME) grant programs aimed at tackling gender and racial disparities in migraine...
TriLink BioTechnologies & IVI Sign MOU to Develop mRNA Vaccines
TriLink BioTechnologies, a Maravai® LifeSciences company and global provider of life science reagents and services, and the International Vaccine Institute (IVI), a non-profit international organization...
NEJM Publishes Phase 2b Data on Oveporexton for Narcolepsy
–Data Demonstrated Statistically Significant Improvements in Primary and Secondary Endpoints with Most Subjects Achieving Near Normal Ranges of Wakefulness and Clinically Meaningful Improvements Across the Broad...
Sensus Healthcare Promotes Skin Cancer Awareness with Non-Invasive Treatments
Innovative SRT-100 Vision (IG-SRT) and SRT Vision Technologies allow dermatologists to treat non-melanoma skin cancer without surgery or patient downtime May is Skin Cancer Awareness...
MJ&M Raises Record $17M for Children’s Health & Education
Record-breaking 13th annual fundraiser featured Eric Church concert, Carolina Herrera fashion show by Neiman Marcus, Miranda Lambert set, and more The 13th annual Mack, Jack & McConaughey (MJ&M) fundraising weekend has set...
Blue Shield of CA Awards $300K to Support Youth Mental Health
Community investments support Stand for What’s Right Award winners – 10 local organizations improving the well-being of Californians Blue Shield of California today announced the winners of...
Noster research: The Anti-Obesity Potential of Gut Microbes in High-Sugar Diets
A collaborative research team from Kyoto University, Noster Inc., and others, has uncovered a key mechanism by which the gut bacterium Streptococcus salivarius helps prevent obesity linked to...
AREXVY Recommended for Adults 50-59 at Increased RSV Risk
GSK plc (LSE/NYSE: GSK) is pleased that the Advisory Committee on Immunization Practices (ACIP) voted in favor of recommending the use of RSV vaccinesincluding GSK’sAREXVY(Respiratory...